ReviewPulmonary therapy2026
Destroyed Lungs and Surgical Management.
Review in Pulmonary therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Destroyed lung is a radiographic and clinical end-stage condition of chronic pulmonary infection, characterized by irreversible parenchymal destruction and major functional impairment. Medical treatment may control active infection, but established structural damage is usually irreversible. Pneumonectomy remains the conventional surgical option for selected patients with unilateral destroyed lung, although it is associated with considerable perioperative risk. Lung transplantation may be considered only in highly selected patients with end-stage disease, bilateral involvement, severe functional compromise, or failure of conventional resection-based strategies. However, it should not be regarded as a routine substitute for pneumonectomy. This narrative review summarizes the major etiologies, clinical manifestations, and surgical approaches to destroyed lung, with particular attention to the selective role, indications, technical challenges, and limitations of lung transplantation in this setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.